File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Anti-mullerian hormone and cumulative pregnancy outcome in in-vitro fertilization

TitleAnti-mullerian hormone and cumulative pregnancy outcome in in-vitro fertilization
Authors
Issue Date2010
PublisherSpringer New York LLC. The Journal's web site is located at http://springerlink.metapress.com/openurl.asp?genre=journal&issn=1058-0468
Citation
Journal Of Assisted Reproduction And Genetics, 2010, v. 27 n. 8, p. 449-456 How to Cite?
AbstractPurpose: To evaluate the role of Anti-mullerian hormone (AMH) in predicting cumulative pregnancy outcome during in-vitro fertilization (IVF) treatment. Methods: Serum AMH levels on day 6 of ovarian stimulation were taken from 180 women undergoing IVF with or without intracytoplasmic sperm injection (ICSI). The main outcome measures were ongoing pregnancy in the fresh cycle, cumulative ongoing pregnancy and ovarian response. Results: There was a trend of higher median AMH levels in subjects achieving ongoing pregnancy in the fresh IVF cycle. The median AMH levels were significantly higher in subjects attaining ongoing pregnancy cumulatively and in subjects showing ovarian hyper-response in the stimulated cycle. Areas under the ROC curves were 0.606 and 0.792 for the prediction of cumulative ongoing pregnancy and ovarian hyper-response respectively. Conclusions: Serum AMH concentration on day 6 of stimulation was significantly higher in subjects who achieved cumulative ongoing pregnancy in IVF compared to those who did not. Serum AMH is a reasonably good predictor of ovarian hyper-response. © 2010 Springer Science+Business Media, LLC.
Persistent Identifierhttp://hdl.handle.net/10722/167091
ISSN
2015 Impact Factor: 1.858
2015 SCImago Journal Rankings: 0.858
PubMed Central ID
ISI Accession Number ID
References

 

DC FieldValueLanguage
dc.contributor.authorKini, Sen_US
dc.contributor.authorLi, HWRen_US
dc.contributor.authorMorrell, Den_US
dc.contributor.authorPickering, Sen_US
dc.contributor.authorThong, KJen_US
dc.date.accessioned2012-09-28T04:03:38Z-
dc.date.available2012-09-28T04:03:38Z-
dc.date.issued2010en_US
dc.identifier.citationJournal Of Assisted Reproduction And Genetics, 2010, v. 27 n. 8, p. 449-456en_US
dc.identifier.issn1058-0468en_US
dc.identifier.urihttp://hdl.handle.net/10722/167091-
dc.description.abstractPurpose: To evaluate the role of Anti-mullerian hormone (AMH) in predicting cumulative pregnancy outcome during in-vitro fertilization (IVF) treatment. Methods: Serum AMH levels on day 6 of ovarian stimulation were taken from 180 women undergoing IVF with or without intracytoplasmic sperm injection (ICSI). The main outcome measures were ongoing pregnancy in the fresh cycle, cumulative ongoing pregnancy and ovarian response. Results: There was a trend of higher median AMH levels in subjects achieving ongoing pregnancy in the fresh IVF cycle. The median AMH levels were significantly higher in subjects attaining ongoing pregnancy cumulatively and in subjects showing ovarian hyper-response in the stimulated cycle. Areas under the ROC curves were 0.606 and 0.792 for the prediction of cumulative ongoing pregnancy and ovarian hyper-response respectively. Conclusions: Serum AMH concentration on day 6 of stimulation was significantly higher in subjects who achieved cumulative ongoing pregnancy in IVF compared to those who did not. Serum AMH is a reasonably good predictor of ovarian hyper-response. © 2010 Springer Science+Business Media, LLC.en_US
dc.languageengen_US
dc.publisherSpringer New York LLC. The Journal's web site is located at http://springerlink.metapress.com/openurl.asp?genre=journal&issn=1058-0468en_US
dc.relation.ispartofJournal of Assisted Reproduction and Geneticsen_US
dc.subject.meshAdulten_US
dc.subject.meshAnti-Mullerian Hormone - Blooden_US
dc.subject.meshFemaleen_US
dc.subject.meshFertilization In Vitroen_US
dc.subject.meshHumansen_US
dc.subject.meshPregnancyen_US
dc.subject.meshPregnancy Rateen_US
dc.subject.meshRetrospective Studiesen_US
dc.titleAnti-mullerian hormone and cumulative pregnancy outcome in in-vitro fertilizationen_US
dc.typeArticleen_US
dc.identifier.emailLi, HWR: raymondli@hku.hken_US
dc.identifier.authorityLi, HWR=rp01649en_US
dc.description.naturelink_to_subscribed_fulltexten_US
dc.identifier.doi10.1007/s10815-010-9427-2en_US
dc.identifier.pmid20467803-
dc.identifier.pmcidPMC2941584-
dc.identifier.scopuseid_2-s2.0-77956914522en_US
dc.identifier.hkuros222192-
dc.relation.referenceshttp://www.scopus.com/mlt/select.url?eid=2-s2.0-77956914522&selection=ref&src=s&origin=recordpageen_US
dc.identifier.volume27en_US
dc.identifier.issue8en_US
dc.identifier.spage449en_US
dc.identifier.epage456en_US
dc.identifier.isiWOS:000282475100004-
dc.publisher.placeUnited Statesen_US
dc.identifier.scopusauthoridKini, S=27168851100en_US
dc.identifier.scopusauthoridLi, HWR=8554164300en_US
dc.identifier.scopusauthoridMorrell, D=36087680500en_US
dc.identifier.scopusauthoridPickering, S=7101793519en_US
dc.identifier.scopusauthoridThong, KJ=7005739732en_US
dc.identifier.citeulike7193651-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats